Enter legal issue and location
Bijan Esfandiari - Los Angeles, CA
10940 Wilshire Blvd.Suite 1600 Los Angeles, CA 90024
Baum Hedlund Aristei & Goldman, PC
Los Angeles Class Actions Lawyer
Overview
Bijan Esfandiari is a pharmaceutical product liability litigation attorney and a senior shareholder at Baum, Hedlund, Aristei & Goldman in Los Angeles. He has successfully represented clients in state and federal courts across the nation, at both the trial and appellate level, in wrongful death and catastrophic personal injury cases.
He has participated in several cases that have shaped and developed the law for the benefit of injured victims and consumers of pharmaceutical products...
Bijan Esfandiari is a pharmaceutical product liability litigation attorney and a senior shareholder at Baum, Hedlund, Aristei & Goldman in Los Angeles. He has successfully represented clients in state and federal courts across the nation, at both the trial and appellate level, in wrongful death and catastrophic personal injury cases.
He has participated in several cases that have shaped and developed the law for the benefit of injured victims and consumers of pharmaceutical products...
Bijan Esfandiari is a pharmaceutical product liability litigation attorney and a senior shareholder at Baum, Hedlund, Aristei & Goldman in Los Angeles. He has successfully represented clients in state and federal courts across the nation, at both the trial and appellate level, in wrongful death and catastrophic personal injury cases.
He has participated in several cases that have shaped and developed the law for the benefit of injured victims and consumers of pharmaceutical products. In one case of first impression (a case that presents a new issue for legal interpretation), the Court agreed with Bijan's argument and held that drug manufacturers owe an affirmative duty to warn regarding risks associated with children's off-label use.
Bijan's published cases have also exposed reprehensible corporate conduct. In one instance, a federal court in Pennsylvania allowed Bijan's clients to proceed with their punitive damages claims after finding that internal documents demonstrated the defendant had "acted with a wanton and willful disregard for the safety of its consumers."
Where drug makers have tried to convince courts that federal preemption (the doctrine that federal law preempts conflicting state laws) grants them immunity from state lawsuits, Bijan has time and again prevented their escape. In Mason v. SmithKline Beecham Corp., the first and only prescription drug preemption case to be heard by the U.S. Seventh Circuit Court of Appeals, the drug makerargued that FDA approval of a drug shielded its manufacturer from fault even if the company later learned of harmful negative reactions. The court, however, sided with Bijan and held that plaintiffs' claims were not preempted by federal law.
Bijan has likewise successfully opposed preemption in numerous other state and federal court cases. He co-authored amicus briefs in support of the respondents in the Supreme Court's landmark cases Wyeth v. Levine, 129 S.Ct. 1187 (2009) and Pliva v. Mensing, 131 S.Ct. 2567 (2011). Bijan received his bachelor's degree (cum laude, 1999) and J.D. degree from UCLA. He has been selected to Southern California Super Lawyers® - Rising Stars for five years in a row and has an Avvo.com rating of 10 out of 10: Superb.
---
Baum Hedlund has taken on the Zantac cancer litigation after the U.S. Food and Drug Administration (FDA) announced that it is investigating Zantac cancer risks after testing of certain Zantac (ranitidine hydrochloride) tablets found the commonly-used heartburn medication contains a cancer-causing chemical up to 3,000 times greater than the FDA's daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine ("NDMA"). Though the FDA has yet to issue an official Zantac recall, CVS and Walgreens have pulled Zantac and Zantac OTC generics from their shelves and Apotex has voluntarily recalled its ranitidine products from Rite-Aid and Walgreens.- Law Firm Info
- Reviews
- Go through email verification, and reviewers must verify their email addresses.
- Can be confirmed and flagged as a verified client by law firms.
- Can be reported and subjected to removal if they violate FindLaw.com's Terms of Service.
Click here to view our Terms of Service.
Write Your Review
Fields marked with an * are required
